• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Spineology® Appoints new Member to Leadership Team; Spine Veteran Emory Rooney joins as Executive Vice President of Sales

    4/4/24 9:05:00 AM ET
    $ATEC
    $SYK
    Medical/Dental Instruments
    Health Care
    Medical/Dental Instruments
    Health Care
    Get the next $ATEC alert in real time by email

    Spineology Inc. ("Spineology" or the "Company"), the leader in ultra-minimally invasive spine surgery, announced today the addition of Emory Rooney as Executive Vice President, Sales. In this role, Rooney will lead U.S. market growth and sales efforts. Rooney comes to Spineology with extensive spine sales experience, having served in Medical Device fields related to spinal implants and navigation for nearly 20 years.

    "The addition of Emory adds even further conviction about our clear opportunity for growth at Spineology," said Brian Snider, Chief Executive Officer at Spineology. "I have had the opportunity to work with Emory and have seen his impact leading sales teams, building new territories, and establishing customer relationships. His experience and level of commitment bring an added degree of sophistication to our selling process. I have full confidence that he will continue to build an incredible sales team that compels surgeons, distributors, and the market to leverage Spineology technology," added Snider.

    Emory Rooney is joining Spineology with nearly two decades of medical device experience. Prior to joining Spineology, Mr. Rooney spent nearly six years with Alphatec Spine (NASDAQ:ATEC), where he served as the Vice President of Sales, East. Under his leadership his territory grew by ten times, achieving over $100 million in annual sales during his tenure. Prior to his time at ATEC, Mr. Rooney had a successful ten-year career with Stryker (NASDAQ:SYK), beginning with various sales representative roles at Stryker Navigation and Stryker Spine, and advancing into numerous leadership roles as a Branch manager, Regional Sales Manager and Area Vice President. Mr. Rooney also proudly serves as a board member for the International Spine Foundation, a non-profit that serves underprivileged spine patients in need of care. Mr. Rooney received his bachelor's degree in political science from the University of Central Florida.

    "The opportunity to join this growing team of spine experts compelled me to the Spineology organization," said Rooney. "After learning more about the versatility of the Optimesh® technology, and the incredible hospital access garnered by the uniqueness of the implant, one that is supported by IDE level data, it was an easy decision to jump on board. I am thrilled to join an organization that I know is set up for exceptional growth."

    With Mr. Rooney's hire, Spineology furthers its continued organizational expansion across the United States, with a core focus on its OptiMesh portfolio of implants.

    About Spineology

    Spineology Inc. leads the way in ultra-minimally invasive spine surgery, revolutionizing how surgeons treat patients with spinal pathologies. Its proprietary technology, OptiMesh sets the company apart from traditional fusion procedures enabling surgeons to optimize outcomes, while minimizing tissue disruption and enhancing patient recovery. With a strong commitment to patient-centered care, Spineology aspires to provide every spine patient the freedom from pain through the creation and delivery of ultra-MIS solutions.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240404165010/en/

    Get the next $ATEC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATEC
    $SYK

    CompanyDatePrice TargetRatingAnalyst
    Stryker Corporation
    $SYK
    7/9/2026$369.00Outperform
    BMO Capital Markets
    Alphatec Holdings Inc.
    $ATEC
    7/9/2026$11.00Outperform
    BMO Capital Markets
    Stryker Corporation
    $SYK
    4/13/2026$410.00Outperform
    Leerink Partners
    Stryker Corporation
    $SYK
    2/20/2026Outperform
    William Blair
    Stryker Corporation
    $SYK
    1/27/2026$387.00Hold
    TD Cowen
    Stryker Corporation
    $SYK
    1/6/2026$418.00Mkt Perform → Outperform
    Raymond James
    Stryker Corporation
    $SYK
    12/19/2025$440.00Mkt Perform → Mkt Outperform
    Citizens JMP
    Alphatec Holdings Inc.
    $ATEC
    10/28/2025$20.00Buy
    Stifel
    More analyst ratings

    $ATEC
    $SYK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets initiated coverage on Stryker with a new price target

    BMO Capital Markets initiated coverage of Stryker with a rating of Outperform and set a new price target of $369.00

    7/9/26 9:30:57 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    BMO Capital Markets initiated coverage on Alphatec with a new price target

    BMO Capital Markets initiated coverage of Alphatec with a rating of Outperform and set a new price target of $11.00

    7/9/26 9:26:08 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Leerink Partners initiated coverage on Stryker with a new price target

    Leerink Partners initiated coverage of Stryker with a rating of Outperform and set a new price target of $410.00

    4/13/26 9:01:23 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $ATEC
    $SYK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $ATEC
    $SYK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $ATEC
    $SYK
    SEC Filings

    View All

    $ATEC
    $SYK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Stryker expands Mako robotics portfolio with full market release of Mako RPS

    New handheld robotic technology expands the Mako platform and brings Mako robotic-assisted knee replacement to a new segment of the orthopaedic marketStryker announced the U.S. commercial launch of Mako RPS (Robotic Power System) for total knee replacement procedures.The launch introduces Mako Handheld Robotics, expanding the Mako portfolio beyond robotic-arm assisted surgery.Mako RPS combines robotic execution, intraoperative planning and a familiar handheld power tool workflow.PORTAGE, Mich., July 16, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today the U.S. commercial launch of Mako RPS® (Robotic Power System) for total knee replacement pro

    7/16/26 9:05:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    ATEC to Report Second Quarter 2026 Financial Results on August 4, 2026

    Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2026 financial results on August 4, 2026, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET.WebcastTo access the live webcast, please use this link or visit the Investor Relations Events & Presentations section of ATEC’s corporate website.Analyst ParticipationTo participate in the question-and-answer session, analysts must register in advance using this link. Upon registration, access details, including a unique code, will be provided via email.ReplayA replay

    7/15/26 4:35:00 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Stryker to announce second quarter 2026 financial results

    Portage, Michigan, July 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will host a webcast at 4:30 p.m. (Eastern time) on Thursday, July 30, 2026, to discuss its second quarter 2026 financial results.  The live webcast can be accessed at Stryker - Events & Presentations.  An archive of the webcast will also be available at Stryker’s website beginning approximately two hours after the live call ends. An accompanying press release that includes summary financial information for the second quarter will be issued at approximately 4:05 p.m. (Eastern time) and available at Stryker - Press Releases on the day of the webcast. About Stryker Stryker is a global leader in medical technologies and

    7/1/26 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Director Mcginnis Karen K was granted 32,012 shares and sold $48,460 worth of shares (6,050 units at $8.01) as part of a pre-agreed trading plan, increasing direct ownership by 38% to 94,671 units (SEC Form 4) to cover withholding tax

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    6/12/26 5:54:14 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Director Blackford Quentin S. was granted 32,012 shares, increasing direct ownership by 6% to 600,381 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    6/12/26 5:34:58 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Director Valentine Keith was granted 32,012 shares, increasing direct ownership by 14% to 264,283 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    6/12/26 5:30:14 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Stryker Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - STRYKER CORP (0000310764) (Filer)

    6/26/26 3:45:42 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 filed by Alphatec Holdings Inc.

    S-8 - Alphatec Holdings, Inc. (0001350653) (Filer)

    6/11/26 5:01:18 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    SEC Form 144 filed by Alphatec Holdings Inc.

    144 - Alphatec Holdings, Inc. (0001350653) (Subject)

    6/11/26 11:04:34 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Director Valentine Keith bought $996,192 worth of shares (135,000 units at $7.38), increasing direct ownership by 139% to 232,271 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    5/11/26 7:00:05 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Director Bakst Evan bought $201,600 worth of shares (35,000 units at $5.76) (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/26/24 4:32:07 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Director Pelizzon David R bought $149,998 worth of shares (25,796 units at $5.81), increasing direct ownership by 8% to 331,696 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/26/24 4:27:25 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    $SYK
    Leadership Updates

    Live Leadership Updates

    View All

    GE HealthCare appoints medtech leader Kevin Lobo to Board of Directors

    GE HealthCare (NASDAQ:GEHC) announced today the appointment of Kevin A. Lobo, Chair and Chief Executive Officer of Stryker Corporation (NYSE:SYK), to its Board of Directors effective March 13. Mr. Lobo brings more than 25 years of medical technology, operational, and financial leadership experience. His clinical expertise and track record of driving innovation and scaling global businesses make him well qualified to contribute to GE HealthCare's strategic priorities. "Kevin is a seasoned healthcare executive with a deep understanding of the medical technology landscape. His knowledge and insight will further strengthen our Board as we continue to build a more personalized, connected and s

    3/17/26 9:00:00 AM ET
    $GEHC
    $SYK
    Medical Electronics
    Health Care
    Medical/Dental Instruments

    Stryker showcases continued innovation across orthopaedics at AAOS 2026 Annual Meeting

    Evolving technologies and offerings reinforce commitment to shaping the future of orthopaedic care PORTAGE, Mich., March 3, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, showcases its commitment to innovation across orthopaedic specialties with the introduction of the newest additions to the Triathlon® Total Knee System, the expanded Mako SmartRobotics™ portfolio and continued evolution of the power tool portfolio at the American Academy of Orthopaedic Surgeons' (AAOS) 2026 Annual Meeting in New Orleans. Triathlon Gold: Building on the legacy

    3/3/26 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    ATEC Mourns Passing of Board Member Jeffrey P. Rydin

    Alphatec Holdings, Inc. (NASDAQ:ATEC) ("ATEC"), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced with great sadness that Jeffrey P. Rydin, a valued member of its Board of Directors, has passed away at age 59, following a lengthy illness. Mr. Rydin enjoyed nearly three decades of experience in the medical device and healthcare industries, including senior sales leadership roles at Ellipse Technologies, Inc., NuVasive, Inc., and DePuy Spine, Inc. He was one of the earliest to join the ATEC turnaround effort, coming to the Company as a Special Advisor to the Board in September 2016, in which capacity he drove many of the early deci

    11/7/25 9:05:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    $SYK
    Financials

    Live finance-specific insights

    View All

    ATEC to Report Second Quarter 2026 Financial Results on August 4, 2026

    Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2026 financial results on August 4, 2026, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET.WebcastTo access the live webcast, please use this link or visit the Investor Relations Events & Presentations section of ATEC’s corporate website.Analyst ParticipationTo participate in the question-and-answer session, analysts must register in advance using this link. Upon registration, access details, including a unique code, will be provided via email.ReplayA replay

    7/15/26 4:35:00 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio

    Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK announced that it has completed the acquisition of Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology company developing a next-generation intravascular lithotripsy (IVL) platform designed to treat complex peripheral arterial disease. "This acquisition is a significant milestone in expanding our peripheral vascular portfolio and enhancing our ability to address challenging arterial disease," said Kevin Lobo, Chair and CEO, Stryker. "By integrating AVS's innovative CO₂-generated pressure wave technology with Stryker's scale and resources, we are well-positioned to deliver solutions that support p

    5/7/26 4:05:00 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker declares an $0.88 per share quarterly dividend

    Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable July 31, 2026, to shareholders of record at the close of business on June 30, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter.  About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 m

    5/7/26 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $ATEC
    $SYK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Alphatec Holdings Inc.

    SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)

    11/12/24 8:04:57 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D/A filed by Alphatec Holdings Inc. (Amendment)

    SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)

    3/22/24 7:57:56 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Stryker Corporation (Amendment)

    SC 13G/A - STRYKER CORP (0000310764) (Subject)

    2/12/24 10:18:54 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care